Digital Therapeutics Alliance

The LSX World Congress, April 28-30, in London, is a must-attend event for the DTx Industry. This global gathering brings together investors, pharma, and healthtech innovators to drive real-world impact and partnerships. ??? Why should DTx companies attend? ? Investor & Partner Access – Connect with top VCs, pharma, and healthcare leaders actively seeking digital solutions. ? Commercialization Insights – Learn from industry pioneers on scaling, reimbursement, and global market access. ? Regulatory & Policy Focus – Stay ahead with discussions on evolving digital health policies and pathways. ? Networking with Decision-Makers – Engage in high-value meetings that accelerate growth. Learn more about LSX World Congress here: https://lnkd.in/e3tSENdk #DTA #DTx #DigitalTherapeutics #MedTech #DigitalHealth

Congratulations to DTA member, Welldoc, on reaching an incredible milestone! ?? Welldoc has now achieved 50+ patents and unveiled CGM-GPT?, a groundbreaking AI-powered glucose prediction technology. Learn more: https://lnkd.in/e8vDF92j

Digital therapeutics have the power to transform patient care, but adoption challenges often stand in the way. CaryHealth is revolutionizing patient engagement for Life Sciences and digital therapeutics, helping to remove barriers and speed up access to life-changing therapies. Join us for an exclusive look at how CaryHealth's innovative partnership with Otsuka is streamlining the process and making digital therapeutics more accessible than ever. Register for free: https://lnkd.in/exwZ2Cgg Scott Motejunas Tony McDermott Lani Reilly, OTR/L

Is the Tide Turning for Digital Therapeutics? Join us at #Nexus2025 to find out! Check out the Nexus agenda featuring digital therapeutics, AI, digital care, and more: https://lnkd.in/gNriGCPU

Join us in welcoming new DTA member, Nox Health! ?? Nox Health’s mission is to transform lives through the power of sleep, using a combination of data, science, technology, and empathetic care. In 2023, Nox acquired Somryst, the first-ever FDA-approved digital therapeutic for chronic insomnia. Somryst delivers Cognitive Behavioral Therapy for Insomnia (CBT-I) and has been shown to improve sleep quality in over 52 randomized controlled trials and real-world studies. In addition to Somryst, Nox provides at-home testing for sleep apnea and value-based sleep care to meet the needs of over 8,000 members at 32 different companies and counting. Nox also develops cutting-edge sleep diagnostics to help millions of people around the world, as well as serving local residents through a brick-and-mortar sleep clinic in Alpharetta, GA.

Thank you to everyone who joined our webinar on how DTx companies can effectively engage with patient advocacy groups. Based on a joint survey by DTA and PlatformQ, the session highlighted key insights, best practices, and strategies for fostering meaningful partnerships. Missed the discussion? The webinar recording is now available for playback. Plus, our newly released white paper offers a deeper dive into the survey findings and a roadmap for collaboration. ?? Read the white paper: https://lnkd.in/gbq9Z6Sz ? Watch the recording: https://lnkd.in/gXK-mSmp A big thank you to Susan Doughty, Randi O'Hara, Sarah Trafford Koenig, and Donna Rice for sharing their expertise alongside moderator Lani Reilly, OTR/L!

Congratulations to the MedRhythms, Inc. team on this exciting news! ??

Thank you to everyone who joined our webinar, CE Essentials for DTx: Everything You Need for European Success! We had an engaging session exploring the key steps to obtaining CE marking for Class I and above, whether starting from scratch or building on an existing FDA clearance. A huge thank you to our presenter, Manon Marault of Sparta Care, for sharing their knowledge and to our engaged audience for their insightful questions! If you missed the session or want to revisit key points, tune in to the webinar recording: https://lnkd.in/g-2RbSJj #DTx #DigitalTherapeutics #RegulatoryPathways #CEMarking #Reimbursement Emilie Lopes-Fernandes

Uncertainty in healthcare is nothing new—but right now, it feels especially daunting. With regulatory shifts, reimbursement questions, and funding freezes shaking up the landscape, many healthcare innovators are wondering: What comes next? And more importantly, how do we move forward when so much remains unclear? I wrote this article because I believe that uncertainty is not a reason to pause—it’s a reason to act with even more clarity and purpose. While we can’t predict every policy change or market fluctuation, we do know what patients, providers, and the healthcare system need. Those who focus on real, lasting challenges—workforce shortages, operational inefficiencies, and access to care—will not only navigate this moment but emerge as leaders shaping what comes next. Check out my latest piece on how healthcare innovators can turn uncertainty into opportunity by anchoring in what we know to be true and taking bold, strategic action. I'd love to hear your thoughts and reactions, and please feel free to bring others into the conversation. How are you approaching this moment in our industry? https://lnkd.in/gGYnnkDy #healthcareinnovation #digitalhealth #futureofhealthcare #uncertainty

Join us TOMORROW for a webinar on how DTx companies can effectively collaborate with patient advocacy groups to drive meaningful engagement and impact. Based on the results of a joint survey by DTA and PlatformQ, this session will highlight key findings, best practices, and actionable strategies to foster strong partnerships with advocacy organizations. Whether you’re looking to build relationships or enhance existing collaborations, this webinar will provide valuable guidance to align with patient communities and meet shared goals. Register for free: https://lnkd.in/g9xJs3HB